These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29886759)

  • 1. Does thyrotoxic periodic paralysis have a genetic predisposition? A case report.
    Rasheed E; Seheult J; Gibney J; Boran G
    Ann Clin Biochem; 2018 Nov; 55(6):713-716. PubMed ID: 29886759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Screening of Patients with Thyrotoxic Hypokalemic Periodic Paralysis: An Experience from a Tertiary Care Hospital in the Northeast of Brazil.
    Gbefon CY; Sobral CPS; Caldas A; Rocha VCC; Azulay RSS; Nascimento GC; Damianse SSP; Gaspar SAS; Faria MS; Magalhães M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2231-2237. PubMed ID: 34554906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis.
    Schalin-Jantti C; Laine T; Valli-Jaakola K; Lonnqvist T; Kontula K; Valimaki MJ
    Horm Res; 2005; 63(3):139-44. PubMed ID: 15795511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.
    Ryan DP; da Silva MR; Soong TW; Fontaine B; Donaldson MR; Kung AW; Jongjaroenprasert W; Liang MC; Khoo DH; Cheah JS; Ho SC; Bernstein HS; Maciel RM; Brown RH; Ptácek LJ
    Cell; 2010 Jan; 140(1):88-98. PubMed ID: 20074522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis.
    Cheng CJ; Lin SH; Lo YF; Yang SS; Hsu YJ; Cannon SC; Huang CL
    J Biol Chem; 2011 Aug; 286(31):27425-35. PubMed ID: 21665951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis.
    Dias Da Silva MR; Cerutti JM; Arnaldi LA; Maciel RM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4881-4. PubMed ID: 12414843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis.
    Dias da Silva MR; Cerutti JM; Tengan CH; Furuzawa GK; Vieira TC; Gabbai AA; Maciel RM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):367-75. PubMed ID: 11940049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis.
    Vendrame F; Verrienti A; Parlapiano C; Filetti S; Dotta F; Morano S
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):218-20. PubMed ID: 18325191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotoxic periodic paralysis in a Caucasian man without identifiable genetic predisposition: a case report.
    Heydorn A; Bertelsen B; Nolsöe RLM; Eiken P; Kristensen PL
    Thyroid Res; 2023 May; 16(1):10. PubMed ID: 37122018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypokalemic thyrotoxic periodic paralysis: a case report].
    Vandergheynst F; Vandergheynst A; Leleux A; Ducobu J
    Acta Clin Belg; 2002; 57(1):19-22. PubMed ID: 12017751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.
    Li X; Yao S; Xiang Y; Zhang X; Wu X; Luo L; Huang H; Zhu M; Wan H; Hong D
    BMC Neurol; 2015 Mar; 15():38. PubMed ID: 25885757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyrotoxic hypokalaemic periodic paralysis in a Caucasian male].
    Lionet A; Barsumau J; Azar R
    Nephrologie; 2004; 25(1):29-32. PubMed ID: 15022871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotoxic periodic paralysis associated with a mutation in the sodium channel gene SCN4A.
    Lane AH; Markarian K; Braziunene I
    J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1679-82. PubMed ID: 15645704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients].
    Silva MR; Chiamolera MI; Kasamatsu TS; Cerutti JM; Maciel RM
    Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):196-215. PubMed ID: 15611833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes.
    Kung AW; Lau KS; Cheung WM; Chan V
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):158-61. PubMed ID: 16430714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis.
    Ng WY; Lui KF; Thai AC; Cheah JS
    Thyroid; 2004 Mar; 14(3):187-90. PubMed ID: 15072700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotoxic periodic paralysis in a Caucasian man in treatment for Graves' disease.
    Didonna D; D'Alessandro G; De Michele A; Conte M; Storelli A; Totaro M; Altomare E
    Panminerva Med; 2000 Dec; 42(4):293-4. PubMed ID: 11294094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients.
    Kuhn M; Jurkat-Rott K; Lehmann-Horn F
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):49-52. PubMed ID: 25882930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis.
    Wang XY; Ren BW; Yong ZH; Xu HY; Fu QX; Yao HB
    Mol Med Rep; 2015 Oct; 12(4):6267-74. PubMed ID: 26252573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of thyrotoxic periodic paralysis.
    Lin SH; Huang CL
    J Am Soc Nephrol; 2012 Jun; 23(6):985-8. PubMed ID: 22460532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.